COVID-19 vaccination unveiling subclinical Sjögren's syndrome

Clin Exp Rheumatol. 2021 Nov-Dec;39 Suppl 133(6):228-229. doi: 10.55563/clinexprheumatol/u1v6z1. Epub 2021 Sep 14.

Authors

Manuel Ramos-Casals¹, Maite Sainz-de-la-Maza², Africa Muxí³

Affiliations

¹ Department of Autoimmune Diseases, ICMiD, Hospital Clinic, Barcelona, Spain. mramos@clinic.cat.
² Clínic Institute of Ophthalmology, ICOF, Hospital Clinic, Barcelona, Spain.
³ Department of Nuclear Medicine, University of Barcelona, Hospital Clínic, Barcelona, Spain.

PMID: 34524079
DOI: 10.55563/clinexprheumatol/u1v6z1

No abstract available

Publication types

Letter

MeSH terms

COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2
Sjogren's Syndrome* / diagnosis
Vaccination / adverse effects

Substances

COVID-19 Vaccines